| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/06/2002 | CA2438205A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2434671A1 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 09/06/2002 | CA2433036A1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2430192A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/05/2002 | US20020124281 Genetically engineering plant; obtain cells, transform with expression vector containing preferential polypetide, express vector, monitor phenotypic expression of plants |
| 09/05/2002 | US20020124272 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 09/05/2002 | US20020123809 Processes for making cryopreserved composite living constructs and products resulting therefrom |
| 09/05/2002 | US20020123623 Nucleotide sequences coding transcription factor for use in the generation of disease resistant and pest resistant plants |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123481 C-fos induced growth factor (FIGF) and DNA encoding same |
| 09/05/2002 | US20020123471 Useful as a gene transfer vehicle for gene therapy, i.e. of the central nervous system |
| 09/05/2002 | US20020123463 As diagnostics, biosensors and bioreactors, pharmaceuticals |
| 09/05/2002 | US20020123458 Endostatin protein and fragments thereof |
| 09/05/2002 | US20020123427 Plant phosphomevalonate kinases |
| 09/05/2002 | US20020123147 Gene transfer with adenoviruses having modified fiber proteins |
| 09/05/2002 | US20020123146 Cell culture; for use as tool in gene therapy and cel packaging |
| 09/05/2002 | US20020123145 Methods for the replacement, translocation and stacking of DNA in eukaryotic genomes |
| 09/05/2002 | US20020123144 Generation preferential cell culture; obtain cells, culture, adhere cell to surface, flush surface continously, recover cells |
| 09/05/2002 | US20020123143 Cellular composition for use in the treatment and repair of bone and nervous system disorders |
| 09/05/2002 | US20020123142 Generating cell culture; obtain cells, deposit on dextran beadlets, culture, separate cells from beadlets by digestion with dextranase |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123140 Generating preferential dendritic cells in vitro; obtain bone marrow and blood monocyte cells, culture, recover dendritic cells |
| 09/05/2002 | US20020123139 Antibodies which bind specifically to activin receptor like kinases |
| 09/05/2002 | US20020123125 Aerobic fermentation of preferential substances; obtain culture apparatus, dispersing and supplying air, oxygen, or a mixed gas of ammonia to culture through pipe, recover preferential substances |
| 09/05/2002 | US20020123124 Mutant amylase for use in detergents and prepartion of textiles |
| 09/05/2002 | US20020123123 Cutinase variants |
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123114 Polypeptide for use in the diagnosis of cancer of the nervous system |
| 09/05/2002 | US20020123113 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 09/05/2002 | US20020123103 Polypeptide for use in the diagnosis and treatment of genetic disorders |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123093 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123075 Detecting modulators of anti-inflammatory activity; obtain cells, incubate with modulator, monitor adjustment in inflammatory activity |
| 09/05/2002 | US20020123067 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 09/05/2002 | US20020123058 Mapping preferential gene to chromosomal position; obtain cells, map genome, monitor phenotypic expression |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123042 Detection of loss of the wild-type hubub1 gene |
| 09/05/2002 | US20020122818 Methods for isolation, quantification, characterization and modulation of antigen-specific T cells |
| 09/05/2002 | US20020122804 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/05/2002 | US20020122778 Herbal composition for improving oral hygiene, for providing local anesthesia, for use as an oral sensate, flavor enhancer and potentiator, and methods of using same |
| 09/05/2002 | DE19921076A1 Use of nucleic acid, and derived products, from a region of chromosome 3 associated with tumor suppression and cell senescence, for e.g. treatment of tumors |
| 09/05/2002 | DE10106852A1 Entzündungshemmende Verbindungen Anti-inflammatory compounds |
| 09/05/2002 | DE10106827A1 Verwendung eines Konjugats aus Interleukin-6(IL-6) und seinem Rezeptor zur Induktion der zellulären Expression des Stammzellfaktors (SCF) und von Flat-3-Ligand (Flt-3L) Use of a conjugate of interleukin-6 (IL-6) and its receptor in the induction of cellular expression of the stem cell factor (SCF) and Flat-3 ligand (Flt-3L) |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236799A2 Human nucleic acid sequences derived from breast tumor tissue |
| 09/04/2002 | EP1236796A1 Novel enone reductases isolated from Kluyveromyces lactis, methods for producing same, and methods for selectively reducing a carbon-carbon double bond of an Alpha, Beta-unsaturated ketone using the reductases |
| 09/04/2002 | EP1236394A1 Method for rearing house dust mites, preparation of the culture for such method and preparation of allergenic extracts from such mites |
| 09/04/2002 | EP1236046A2 Methods for screening compounds active on neurons |
| 09/04/2002 | EP1236045A2 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 09/04/2002 | EP1235935A1 Targeted methods of drug screening using co-culture methods |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235919A1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 09/04/2002 | EP1235916A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 09/04/2002 | EP1235915A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235906A1 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
| 09/04/2002 | EP1235903A2 Metabollically engineered cells overexpressing pyruvate carboxylase or pyruvate phosphoenolpyruvate carbokylase, and methods to produce and use such cells |
| 09/04/2002 | EP1235902A1 Olfactory ensheathing cells isolated from the lamina propria |
| 09/04/2002 | EP1235901A2 Method and compositions for producing cell transplants |
| 09/04/2002 | EP1235900A1 Microparticle-based transfection and activation of dendritic cells |
| 09/04/2002 | EP1235899A1 Treatment of human infertility |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235859A1 New olfactory receptor polypeptides and dna sequences thereof |
| 09/04/2002 | EP1235857A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 09/04/2002 | EP1235848A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 09/04/2002 | EP1235847A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235845A2 24 human secreted proteins |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235842A1 Rna interference pathway genes as tools for targeted genetic interference |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235586A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 09/04/2002 | EP1235585A2 Use of a milk protein hydrolysate in the treatment of diabetes |
| 09/04/2002 | EP1235518A1 Personal cervical cell collector |
| 09/04/2002 | EP1235485A2 Lung stem cells and lung regeneration |
| 09/04/2002 | EP1235482A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 09/04/2002 | EP1105508B1 Method for purifying biomolecule or protein complexes |
| 09/04/2002 | EP1098957B1 Transferring materials into cells using porous or polycrystalline silicon |
| 09/04/2002 | EP0999849B1 Use of lbp in the treatment of septicaemia |
| 09/04/2002 | EP0986640B1 Transgenic fish with tissue-specific expression |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0787180B1 Active retinoic acid free culture medium for avian totipotential embryonic cells |
| 09/04/2002 | EP0711355B1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | CN1367876A Method for separating cells using immunorosettes |
| 09/04/2002 | CN1367838A Promoters for expressing genes in fungal cell |
| 09/04/2002 | CN1367836A CHP polypeptide as ligand of PAK65 |
| 09/04/2002 | CN1367831A Use of BNM3 transcriptional activator to control plant embryogenesis and regeneration process |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |